LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Diffraction Phase Microscopy Reveals Mechanics of Erythrocyte Membranes

By LabMedica International staff writers
Posted on 29 Apr 2010
Image: Erythrocytes (photo courtesy Mustafa Mir, Sam Copeland, and Gabriel Popescu. Additional information may be found at http://light.ece.uiuc.edu).
Image: Erythrocytes (photo courtesy Mustafa Mir, Sam Copeland, and Gabriel Popescu. Additional information may be found at http://light.ece.uiuc.edu).
A novel measurement technique called diffraction phase microscopy uses two beams of light in contrast to other microscopes that only use one.

Using diffraction phase microscopy a team of scientists developed a model that could lead to breakthroughs in screening and treatment of blood-cell-morphology diseases, such as malaria, sickle-cell disease, and spherocytosis. It could also be used to screen banked blood for membrane flexibility before transfusion, since stored blood often undergoes cellular shape changes.

In circulation, erythrocytes or red blood cells (RBCs) must contort to squeeze through capillaries half their diameter. Their flexibility and resilience come from their membrane structure, which couples a typical lipid bilayer with an underlying matrix of protein. However, knowledge of the membrane's mechanics is very limited.

Prof. Gabriel Popescu of the electrical and computer engineering department at the University of Illinois at Urbana Champaign (Champaign, IL, USA) and colleagues were able to see nanoscale membrane fluctuations in live cells, and to measure them quantitatively. The group published its findings in the April 13, 2010 publication of the Proceedings of the [U.S.] National Academy of Sciences (PNAS).

In addition to normal cells, the team also measured two other morphologies: bumpy RBCs called echinocytes and round ones called spherocytes. They discovered that these deformed cells display less flexibility in their membranes, a finding that could provide insight into mechanics and treatment of diseases.

Because diffraction phase microscopy measures live cells without physically manipulating or damaging them, it also could be used to evaluate medications being developed to treat blood cell morphology diseases, according to Prof. Popescu. "We can study the mechanics of a single cell under different pharmacological conditions, and I think that would be ideal for testing drugs," he said.

Related Links:
University of Illinois at Urbana Champaign


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Alcohol Testing Device
Dräger Alcotest 7000

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more